Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Institut National De La Sante Et De La Recherche Medicale inserm
Institut National De La Sante Et De La Recherche Medicale
Institut National De La Sante Et De La Recherche Medicale Inserm
Institut National De La Sante Et De La Recherche Medicale i n s e r m
Institut National De La Sante Et De La Recherche Medicale I n s e r m
Institut National De La Sante Et De La Recherche Medicale inserm fr fr
Institut National De La Sante Et De La Recherche Medicale_20100114
Institut National De La Sante Et De La Recherche Medicale inserm_20100121
Institut National De La Sante Et De La Recherche Medicale inserm U1032

Institut National De La Sante Et De La Recherche Medicale patents


Recent patent applications related to Institut National De La Sante Et De La Recherche Medicale. Institut National De La Sante Et De La Recherche Medicale is listed as an Agent/Assignee. Note: Institut National De La Sante Et De La Recherche Medicale may have other listings under different names/spellings. We're not affiliated with Institut National De La Sante Et De La Recherche Medicale, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Institut National De La Sante Et De La Recherche Medicale-related inventors


Treatment of facioscapulohumeral dystrophy

The present invention relates to nucleic acids, compositions and methods for the treatment of facioscapulohumeral dystrophy.... Institut National De La Sante Et De La Recherche Medicale

Simulation system, corresponding devices, methods and programs

A module for simulating an operative procedure within a virtual environment. The virtual environment is implemented by using a device for processing virtual environment data. The module includes: a module configured to obtain a data structure representing a set of objects of the virtual environment and having at least one... Institut National De La Sante Et De La Recherche Medicale

Use of hepcidin as a regulator of iron homeostasis

The invention concerns the use of hepcidin for the diagnosis and therapy of disorders of iron homeostasis. Hepcidin can be used in the treatment of disorders resulting from iron overload while inhibitors of hepcidin can be used in the treatment of anaemia.... Institut National De La Sante Et De La Recherche Medicale

Method for unsuper vised sorting in real time of action potentials of a plurality of biological neurons

A method for unsupervised sorting, in real time, of action potentials of biological neurons by a network of artificial neurons including input, intermediate and output layers, the method according to which: the input layer receives an electrical signal measuring an electrical activity of biological neurons, the electrical signal having a... Institut National De La Sante Et De La Recherche Medicale

System for the ablation or the monitoring of a zone of the heart by ultrasounds and associated methods

A system for ablating or monitoring a zone of the heart, includes a system to measure the heart electrical activity; a phased array for generating a beam of focussed ultrasound signals on a targeted zone of the heart; an imaging system determining an image of a transcostal wall projected in... Institut National De La Sante Et De La Recherche Medicale

Focussed ultrasound cardiac stimulation system, portable device and cardiac stimulation, and associated methods

An ultrasound cardiac stimulation system includes: a system for measuring the heart electrical activity; a system for generating a beam of focussed ultrasound signals focussed on a targeted zone, the signals being calibrated to generate electrical stimulation in a zone of the heart, the beam generation being synchronised with a... Institut National De La Sante Et De La Recherche Medicale

Combination of biomarkers for detecting and evaluating a hepatic fibrosis

optionally, at least one gene from among the list of the following sixteen genes: IL6ST, p14ARF, MMP9, ANGPT2, CXCL11, MMP2, MMP7, S100A4, TIMP1, CHI3L1, COL1A1, CXCL1, CXCL6, IHH, IRF9 and MMP1.... Institut National De La Sante Et De La Recherche Medicale

New in vitro blood-brain barrier model

The invention is in the domain of delivery of molecules to brain cells across the blood-brain barrier. The invention relates to a novel polypeptide-based carrier that allows the efficient delivery of an effector peptide, to neuron cells across the blood-brain barrier, and to methods for the production and testing of... Institut National De La Sante Et De La Recherche Medicale

In vitro the detection and quantification of hiv-2

The present invention relates to a method for detecting or quantifying Human Immunodeficiency Virus-2 (HIV-2) nucleic acids in a biological sample, comprising: a) performing a real-time polymerase chain reaction (PCR) or a real-time reverse transcriptase polymerase chain reaction (RT-PCR) on nucleic acids of the biological sample with: (i) at least... Institut National De La Sante Et De La Recherche Medicale

Treatment of amyotrophic lateral sclerosis

The invention relates to a method for the treatment of amyotrophic lateral sclerosis (ALS). Specifically, the invention implements the use of an antisense sequence adapted to affect alternative splicing in a human SOD1 pre-mRNA, thereby leading to the destruction of the skipped m RNA by the cell machinery.... Institut National De La Sante Et De La Recherche Medicale

Methods of generating corneal cells and cell populations comprising same

A method of generating a population of corneal epithelial cells is disclosed. The method comprises culturing human pluripotent stem cells in corneal fibroblast-conditioned medium on a solid surface comprising an extracellular matrix component thereby generating the population of corneal epithelial cells. Isolated cell populations and corneal tissues are also disclosed,... Institut National De La Sante Et De La Recherche Medicale

Compositions having means for targeting at least one antigen to dendritic cells

A composition that can be used as a vaccine containing means for targeting at least one antigen to dendritic cells and as adjuvants a granulocyte macrophage colony stimulating factor and a CpG oligodeoxynucleotide and/or a CpG-like oligodeoxynucleotide. This composition can used to treat cancers, infectious diseases caused by bacterial, viral,... Institut National De La Sante Et De La Recherche Medicale

Treatment of myotonic dystrophy

The present invention relates to compositions and methods for treating myotonic dystrophy.... Institut National De La Sante Et De La Recherche Medicale

Piperazine phenothiazine derivatives for treating spasticity

The present invention relates to piperazine phenothiazine derivatives useful as therapeutic agents for treating spasticity, particularly following an ischemia or traumatic injury, or compression syndrome. The invention further relates to a pharmaceutical composition comprising a compound of the invention for treating spasticity.... Institut National De La Sante Et De La Recherche Medicale

New target for diabetes treatment and prevention

The present invention relates to the identification of ALMS1 as the missing player involved in the regulation of the insulin-mediated glucose uptake through GLUT4 sorting vesicles, and to the down-regulation of ALMS1 by αPKC. Accordingly, the present invention relates to a molecule capable of preventing the binding of αPKC on... Institut National De La Sante Et De La Recherche Medicale

Novel antiviral compositions for treating the flu

The present invention relates to a pharmaceutical or veterinary composition for the use thereof in preventing and/or treating infection by the influenza viruses. Said composition is characterized in that it contains, in an appropriate pharmaceutical carrier, at least one compound selected from among Etilefrine and Diltiazem.... Institut National De La Sante Et De La Recherche Medicale

Vaccines for preventing meningococcal infections

The present invention stems from the finding that the interaction between the β2 adrenoceptor (β2AP) and type IV pilus-associated proteins initiates a process leading to the opening of the blood brain barrier. The invention therefore pertains to a vaccine for preventing the spreading of meningococci into the meningeal space, wherein... Institut National De La Sante Et De La Recherche Medicale

Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus

The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.... Institut National De La Sante Et De La Recherche Medicale

Tetrahydroquinoline derivatives and their use as epac inhibitors

The invention relates to tetrahydroquinoline derivatives and their use in the treatment and/or the prevention of a disease wherein the Epac protein is involved, such as inflammation, cancer, vascular diseases, kidney diseases, cognitive disorders and cardiac diseases.... Institut National De La Sante Et De La Recherche Medicale

Anti-mesothelin antibodies and uses thereof

The present disclosure provides isolated nanobodies based on camelid VHH domains that specifically bind to mesothelin with high affinity. Also disclosed are conjugate constructs comprising the isolated nanobodies derivatized to allow conjugation to or that are conjugated to accessory moieties, such as biologically active moieties (e.g., a cytotoxin, a non-cytotoxic... Institut National De La Sante Et De La Recherche Medicale

Process and device for separating biological particles contained in a fluid by means of filtration

The invention relates to a method of separating biological particles from the liquid containing same for purification, analysis and optionally diagnostic purposes. The inventive method comprises at least one step involving vertical filtration through a filter having a porosity that is adapted to the type of biological particles to be... Institut National De La Sante Et De La Recherche Medicale

Anti il-34 antibodies

The present disclosure relates to novel anti IL-34 antibodies or antigen-binding fragments thereof specifically binding cytokine IL-34 with high affinity, the method of obtaining of these antibodies and their therapeutic use.... Institut National De La Sante Et De La Recherche Medicale

Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies

The present invention relates to the diagnosis of acquired sensory neuronopathies (SNN), and to the treatment of these disorders.... Institut National De La Sante Et De La Recherche Medicale

Method of culturing segmented filamentous bacteria in vitro

The present invention relates to an in vitro method of culturing a segmented filamentous bacterium strain, comprising co-culturing said segmented filamentous bacterium strain with a eukaryotic host cell, wherein the culture is performed at an O2 level inferior to 5% in a rich tissue culture liquid medium containing bacterial medium... Institut National De La Sante Et De La Recherche Medicale

Use of a reverse-transcriptase inhibitor in the prevention and treatment of degenerative diseases

The invention relates to the use of a reverse-transcriptase inhibitor in the prevention or treatment of a degenerative disease.... Institut National De La Sante Et De La Recherche Medicale

Flt3 receptor antagonists for the treatment or the prevention of pain disorders

The present invention relates to FLT3 receptor antagonists or inhibitors of FLT3 receptor gene expression for the treatment or the prevention of pain disorders.... Institut National De La Sante Et De La Recherche Medicale

Anti-angiogenic properties of collagen v derived fragments

The present invention relates to a peptide comprising an amino acid sequence at least 85% identical to the amino acid sequence as shown in SEQ ID NO. 1, wherein the residues Lys905, Arg909, and Arg912 contained therein are present, for use as a medicament, in particular for its use as... Institut National De La Sante Et De La Recherche Medicale

Porous polysaccharide scaffold comprising nano-hydroxyapatite and use for bone formation

The present invention relate to three dimensional porous polysaccharide matrices able to induce mineralisation of a tissue in osseous site, as well as in non-osseous site, in the absence of stem cells or growth factors.... Institut National De La Sante Et De La Recherche Medicale

Diagnostic of obliterative arteriopathies

The invention relates to a method of diagnosis or prognosis of an obliterative arteriopathy in a subject, comprising determining the expression level of adenosine A2A receptors expressed at the cell surface of peripheral blood mononuclear cells obtained from said subject. The invention also relates to an agonist-like monoclonal antibody directed... Institut National De La Sante Et De La Recherche Medicale

Time-controlled glucose releasing hydrogels and applications thereof

The present invention relates generally to a hydrogel releasing glucose in a time-controlled manner, to medical applications thereof, and to a method for preparing said hydrogel.... Institut National De La Sante Et De La Recherche Medicale

Novel aminopyridine compounds useful as inhibitors of protein prenylation

group. Also disclosed are novel compounds of formulae (I) and (II).... Institut National De La Sante Et De La Recherche Medicale

Mutant bordetella strains and methods of use

A method of reducing or preventing the development of airway inflammation in a subject includes the step of infecting the respiratory tract of a subject an amount of a composition including a pharmaceutically acceptable carrier and live attenuated pertactin-deficient Bordetella bacteria sufficient to colonize the respiratory tract of the subject.... Institut National De La Sante Et De La Recherche Medicale

Nitrogen-containing analogs of salinomycin, synthesis and use against cancer stem cells and malaria

The present invention concerns compounds of formula (I), enantiomers, mixture of enantiomers, diastereoisomers and mixture of diasteroisomers thereof formula (I): wherein at least one of W, X and Y is selected from the group consisting of —NR1R2; —NR3—(CH2)n—NR4R5; —O—(CH2)n—NR4R5; —NR3—(CH2)n—N′R6R7R8; and —O—(CH2)n—N′R6R7R8 and Z is a functional group capable of... Institut National De La Sante Et De La Recherche Medicale

Microfluidic device with one microchannel for multiple detection

The present invention relates to a microfluidic device (2) comprising a support part (21) and a cover part (22) defining together a microchannel (5), said microchannel (5) having a surface, said surface comprising:—a first area (9) which is grafted with a first ligand, and—at least a second area (10) which... Institut National De La Sante Et De La Recherche Medicale

Bola-amphiphilic compounds and their uses for biomedical applications

The invention relates to bola-amphiphilic compounds and their uses for biomedical application. The invention particularly relates to the use of bola-amphiphilic compounds for providing low molecular weight gels (LMWG), useful, in particular, as culture media for animal or human cells, or as biocompatible material for biomedical applications.... Institut National De La Sante Et De La Recherche Medicale

08/24/17 / #20170241902

Method for correcting an infrared absorption spectrum

A method for correcting an infrared absorption spectrum comprises the steps of:—providing a measured infrared absorption spectrum from a sample,—determining a baseline correction curve by using at least one spectral interval in which an absorption quantity is expected to be null for at least two wavelength quantities,—subtracting the baseline correction... Institut National De La Sante Et De La Recherche Medicale

08/24/17 / #20170242026

Methods and tools for detecting interactions in eukaryotic cells using microtubule structures and dynamics

A method for detecting an interaction between one or more protein bait and one or more candidate prey in a eukaryotic cell, comprising the steps of: a) providing an eukaryotic cell expressing (i) one or more protein bait, and (ii) one or more candidate prey, wherein said protein bait comprises... Institut National De La Sante Et De La Recherche Medicale

08/24/17 / #20170242038

Compositions useful in the diagnostic of latently infected mycobacterium tuberculosis

The present invention concerns a composition comprising at least three peptides derived from Mycobacterium tuberculosis antigen Rv2626c, its use in the diagnostic of latently infected Mycobacterium tuberculosis (LTBI) subjects, corresponding methods of use and kits.... Institut National De La Sante Et De La Recherche Medicale

08/24/17 / #20170242281

Method for determining the characteristics of a system for generating a spatial light modulation in phase and amplitude at high refresh rate

Method for determining the characteristics of a system for generating at least one pattern of light, the method comprising: a) providing a desired pattern of light, b) expressing the amplitude and the phase of the output pulse of the system as a function of the input laser pulse and in... Institut National De La Sante Et De La Recherche Medicale

08/17/17 / #20170234731

Method for determining absorption bands

The present invention concerns a method for determining at least one absorption band in a spectrum, the method at least comprising the steps of:—providing a measured absorption spectrum from the sample,—providing a calculation spectrum,—from the calculation spectrum, extracting at least one absorption band,—calculating a residual spectrum by removing each extracted... Institut National De La Sante Et De La Recherche Medicale

08/10/17 / #20170224638

Methods for the treatment of tinnitus induced by cochlear excitotoxicity

The invention relates to methods for the prevention and/or treatment of tinnitus induced by cochlear excitotoxicity. In these methods, a pharmaceutical composition comprising an NMDA receptor antagonist is administered to an individual in need of such treatment by appropriate devices and/or formulations for local administration to the inner ear. The... Institut National De La Sante Et De La Recherche Medicale

08/03/17 / #20170216417

Population of immunoregulatory t cells specific for an irrelevant antigen and uses thereof for preventing or treating immune diseases

The present invention relates methods and compositions for preventing or treating various immune diseases including graft-versus-host disease (GVHD) using populations or compositions of immunoregulatory T cells specific for an irrelevant antigen; such cells being activated in vivo by a simultaneous, separate or sequential administration of said antigen.... Institut National De La Sante Et De La Recherche Medicale

07/27/17 / #20170209597

Capped and uncapped rna molecules and block copolymers for intracellular delivery of rna

The present invention relates to the use of at least one tetra functional non-ionic amphiphilic block copolymer as a vehicle for capped or uncapped mRNA for intracellular delivery for gene therapy.... Institut National De La Sante Et De La Recherche Medicale

07/27/17 / #20170210714

Macrocyclic complexes, their process of preparation and use as pet imaging agents

The present invention concerns compounds of formula (I): their process of preparation and compositions thereof. The present invention also concerns their use as diagnostic agent in PET imaging.... Institut National De La Sante Et De La Recherche Medicale

06/29/17 / #20170181729

Method for obtaining a functional parameter of a muscle

The present invention concerns a method for obtaining a functional parameter of a muscle having a part, the method comprising the steps of: a) applying ultrasound waves to the muscle, b) collecting the ultrasound waves retrodiffused by the muscle at a plurality of times, to obtain collected ultrasound waves, c)... Institut National De La Sante Et De La Recherche Medicale

06/29/17 / #20170183306

Cyclic compounds having a 1,3 diamino-functionality for use in the treatment of hiv infection

The present invention relates to compounds, capable of activating HIV expression in reservoir cells, of formula (I) for use in the treatment of HIV infection.... Institut National De La Sante Et De La Recherche Medicale

06/22/17 / #20170174716

Fumarate-co-releasing molecule hybrids, their use in the treatment of inflammatory or cardiovascular diseases and their process of preparation

The present invention relates to hybrid fumarate-CO-releasing molecules capable of increasing heme oxygenase-1 (HO-1) activity and HO-1 protein expression and simultaneously releasing CO, their synthesis and their use in therapeutic applications, in particular their use in the treatment of inflammatory or cardiovascular diseases.... Institut National De La Sante Et De La Recherche Medicale

06/22/17 / #20170175196

Diagnosis of hereditary spastic paraplegias (hsp) by detection of a mutation in the kiaa1840 gene or protein

An ex vivo method of diagnosing or predicting an hereditary spastic paraplegias (HSP) in a subject is provided which comprises detecting a mutation in the KIAA1840 gene or protein (spatacsin), wherein that mutation is indicative of an hereditary spastic paraplegias (HSP).... Institut National De La Sante Et De La Recherche Medicale

06/15/17 / #20170166643

Recombinant monovalent antibodies

The invention relates to recombinant monovalent antibodies which are heterodimers of a first protein chain comprising the variable domain of the heavy chain of an antibody of interest and the CH2 and CH3 domains of an IgG immunoglobulin and a second protein chain comprising the variable domain of the light... Institut National De La Sante Et De La Recherche Medicale

05/11/17 / #20170128564

Polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual

The present invention relates to the field of the in vitro diagnosis of the progression status of an infection of an individual with a virus belonging to the family of the Human Immunodeficiency Viruses (HIV) as well as with the therapeutical treatment of this infectious disease. The invention also relates... Institut National De La Sante Et De La Recherche Medicale

05/04/17 / #20170124294

Method of characterizing molecular diffusion within a body from a set of diffusion-weighted magnetic resonance signals and carrying out such a method

A computer-implemented method of characterizing molecular diffusion within a body from a set of diffusion-weighted magnetic resonance signals by computing a weighted average of a plurality of multi-compartment diffusion models comprises a same number of compartments, fitted to a set of diffusion-weighted magnetic resonance signals, the weighted average being computed... Institut National De La Sante Et De La Recherche Medicale

04/27/17 / #20170114136

Anti-cd28 humanized antibodies

The invention relates to humanized antibodies directed against the human lymphocyte receptor CD28. When used in a monovalent form these antibodies are antagonists, i.e. capable of blocking of the CD28/B7 interaction, without activating CD28. These antibodies can be used in particular as therapeutic agents for blocking T cell activation through... Institut National De La Sante Et De La Recherche Medicale

04/20/17 / #20170106074

Influenza vaccine, composition, and methods of use

The invention relates to compositions and vaccines that include a mutated Bordetella strain for treating or preventing an influenza infection in a mammal. In addition, the invention further provides methods for protecting a mammal against infection by influenza and/or eliciting an immune response against an influenza virus in a mammal... Institut National De La Sante Et De La Recherche Medicale

03/16/17 / #20170073637

Pooled nk cells from ombilical cord blood and their uses for the treatment of cancer and chronic infectious disease

The invention relates to the field of cell therapy, particularly NK cell mediated therapy. The present invention relates to a method of producing an ex vivo population of cells, preferably NK cells, from at least two umbilical cord blood units (UCB units), or fraction thereof containing said cells, by pooling... Institut National De La Sante Et De La Recherche Medicale

03/16/17 / #20170074891

Detection of shed cd31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways

The present invention stems from the finding that the extracellular domain of CD31 proteins present on blood leukocytes is shed and released in the circulation as a soluble form of CD31. A method for detecting shed CD31 is further disclosed. The invention therefore relates to a method for detecting a... Institut National De La Sante Et De La Recherche Medicale

03/09/17 / #20170067910

Detection of platelet-derived shed cd31

The present invention relates to various soluble forms of CD31, including a novel form which is shed by activated platelets and released into the circulation. Methods for detecting said soluble forms of CD31 are disclosed, as are methods of specifically 1 detecting said platelet-derived shed CD31 and the use of... Institut National De La Sante Et De La Recherche Medicale

03/02/17 / #20170056500

Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction

The invention relates generally to neuroprotection and repair in neurological disorders involving Tan dysfunction (including Alzheimer's disease). The invention describes AND INCLUDES a direct interaction between proteins FKBP52 mid Tau. More particularly, the invention relates to a method for screening a drug for the prevention and treatment of neurological disorders... Institut National De La Sante Et De La Recherche Medicale

02/23/17 / #20170051253

Method and device for conserving viable and functional human polymorphonuclear neutrophils

A method for keeping leukocytes alive ex vivo or in vitro, comprising maintaining the leukocytes in a medium comprising from 3 to 10 mM of glucose, in hypoxic conditions with P(02)≦10 mM Hg.... Institut National De La Sante Et De La Recherche Medicale

02/09/17 / #20170037067

New lipophenol compounds and uses thereof

The present invention relates to a compound of formula (I) wherein: —i is 0 or 1; j is 0 or 1; k is 0 or 1; —R1 and R2 are in particular H, (C1-C12)alkyl, or a group of formula C(O)R; —R is a, linear or branched, alkyl radical, comprising at... Institut National De La Sante Et De La Recherche Medicale

02/02/17 / #20170028006

Use of cranberry proanthocyanidin for treatment of oropharyngeal bacterial colonization

The present invention relates to a method for preventing Gram-negative bacterial colonization of an oropharyngeal material, the said method comprising bringing into contact a composition comprising a cranberry-derived proanthocyanidin extract on at least a part of the surface area of the said material.... Institut National De La Sante Et De La Recherche Medicale

01/05/17 / #20170000846

Use of a neurofilament peptide for the treatment of glioma

The present invention provides a new drug to treat malignant glioma, which is the most prevalent type of primary tumor of the central nervous system (CNS). The present invention indeed shows that the isolated NFL-TBS40-63 peptide is highly specific for glioma cells, in which it triggers apoptosis. It is therefore... Institut National De La Sante Et De La Recherche Medicale

01/05/17 / #20170000849

Cd300a receptors as virus entry cofactors

The present invention concerns an inhibitor of an interaction between CD300a and an aminophospholipid for use in preventing or treating a virus infection by inhibition of the interaction between CD300a and viral aminophospholipid.... Institut National De La Sante Et De La Recherche Medicale

02/08/18 / #20180036558

Interstitial ultrasonic disposable applicator and tissue thermal conformal volume ablation and monitoring the same

An interstitial ultrasound thermal ablation applicator for conformal treatment of an inhomogeneous tumor lesion includes: a body having a longitudinal axis; and a plurality of array transducers mounted on the body, arranged side by side and having azimuth directions parallel to the longitudinal axis of the body, and having outer... Institut National De La Sante Et De La Recherche Medicale

12/28/17 / #20170368822

Laser printing for implementing said method

A method for printing uses at least one ink. The method includes: a step of focusing a laser beam so as to generate a cavity in an ink film; a step of forming at least one ink droplet from a free surface of the ink film; and a step of... Institut National De La Sante Et De La Recherche Medicale

11/09/17 / #20170320263

Method for laser printing biological components, and device for implementing said method

A method for printing uses at least one bio-ink. The method also uses at least one laser print head to deposit at least one droplet of at least one bio-ink onto a depositing surface of a receiving substrate. The printing method uses at least one nozzle print head to deposit... Institut National De La Sante Et De La Recherche Medicale

Patent Packs







ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Institut National De La Sante Et De La Recherche Medicale in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Institut National De La Sante Et De La Recherche Medicale with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###